Sargent Bickham Lagudis’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
$207K Hold
3,060
0.02% 266
2022
Q3
$152K Sell
3,060
-44
-1% -$2.19K 0.01% 267
2022
Q2
$173K Buy
3,104
+246
+9% +$13.7K 0.02% 264
2022
Q1
$159K Hold
2,858
0.01% 278
2021
Q4
$160K Hold
2,858
0.01% 271
2021
Q3
$137K Sell
2,858
-682
-19% -$32.7K 0.01% 291
2021
Q2
$148K Sell
3,540
-140
-4% -$5.85K 0.01% 296
2021
Q1
$124K Buy
3,680
+168
+5% +$5.66K 0.01% 309
2020
Q4
$123K Buy
3,512
+1,662
+90% +$58.2K 0.01% 301
2020
Q3
$64K Hold
1,850
0.01% 347
2020
Q2
$61K Hold
1,850
0.01% 331
2020
Q1
$56K Hold
1,850
0.01% 325
2019
Q4
$54K Hold
1,850
0.01% 371
2019
Q3
$48K Sell
1,850
-2,074
-53% -$53.8K 0.01% 357
2019
Q2
$100K Sell
3,924
-400
-9% -$10.2K 0.01% 283
2019
Q1
$113K Sell
4,324
-580
-12% -$15.2K 0.01% 269
2018
Q4
$113K Hold
4,904
0.01% 253
2018
Q3
$116K Hold
4,904
0.01% 257
2018
Q2
$113K Hold
4,904
0.01% 258
2018
Q1
$121K Hold
4,904
0.02% 255
2017
Q4
$132K Hold
4,904
0.02% 253
2017
Q3
$118K Hold
4,904
0.01% 267
2017
Q2
$105K Hold
4,904
0.01% 265
2017
Q1
$84K Sell
4,904
-4,642
-49% -$79.5K 0.01% 288
2016
Q4
$171K Buy
9,546
+8,782
+1,149% +$157K 0.03% 213
2016
Q3
$2.41K Sell
764
-131,350
-99% -$414K 0.36% 76
2016
Q2
$3.55M Buy
132,114
+6,040
+5% +$162K 0.55% 53
2016
Q1
$3.42M Buy
+126,074
New +$3.42M 0.55% 56